|[December 16, 2013]
Patient Engagement Systems® Researchers Find Laboratory Confusion, Lack of Clarity are Barriers to Diabetic Nephropathy Screening; Primary Care Automated Clinical Decision Support Tool Yields Improved Quality of Care, Lower Costs
BURLINGTON, Vt. --(Business Wire)--
A study just published in ASCP Lab Medicine led by the University
of Vermont College of Medicine and Patient Engagement Systems® (PES)
researchers found that confusion induced by similarities of test names,
result ranges and design errors in test ordering systems are among the
leading factors contributing to substantial, undetected long-term
failure to correctly screen for kidney damage in patients with diabetes.
Patient Engagement Systems is a fast growing healthcare
patient-physician engagement and analytics company.
The University of Vermont College of Medicine and Patient Engagement
Systems' study titled "Improving Testing for Proteinuria in Diabetes
Using Decision Support: Role of Laboratory Ordering Systems" was led
by Charles D. MacLean, MD., Michael MacCaskey, and Benjamin Littenberg,
MD. Both Drs. Littenberg and MacLean are professors of Medicine at The
University of Vermont; all three are associated with Patient Engagement
Systems, which supported the research. http://labmed.ascpjournals.org/content/44/4/353.abstract
Dr. Littenberg explains, "We installed the Patient Engagement Systems
diabetes clinical decision support system in two large primary care
organizations during 2009-2010, provding reminders to clinicians and
patients regarding overdue laboratory testing. The system was previously
developed by the University of Vermont and proven effective in a
National Institutes of Health funded trial."
After installing the system in these two practice organization, rates of
guideline-concordant proteinuria testing were lower than anticipated.
Investigation of the underlying causes showed, among other issues,
problems with test ordering systems that lead to systematic ordering of
the incorrect test.
The results, says Littenberg, are important for several reasons. "First,
these tests are essential to detecting early kidney damage and
preventing renal failure. Second, in many cases, the labs were reporting
a different test than what the providers thought they were getting - a
very dangerous situation for patient safety. And, finally, the costs of
the incorrect tests were adding to the skyrocketing expenditures for
Introduction of the registry-based Patient Engagement System led to
detection of system wide problems and monitoring the effectiveness of
solutions. Correct proteinuria testing improved from 42.5% to 64.6% (P
Underscoring the significance of this study, Dr. MacLean explains, "This
is an example of how a system to improve patient engagement can also
function as a way to improve quality across a whole system of health
care, improving outcomes and lowering costs."
For more information contact Patient Engagement Systems, Stanley
Goldstein, CEO, 617-504-8853, email@example.com.
About Patient Engagement Systems®
Patient Engagement Systems® (PES) is a nationally recognized healthcare
services company dedicated to supporting its customers' goal of helping
people with chronic diseases, specifically diabetes and chronic kidney
disease, improve their health, and reduce costs. PES provides medical
groups, IPAs, health plans, health systems and government agencies with
automated patient engagement tools, timely clinical decision support and
the analytics needed to better identify, manage and monitor these high
cost patients. PES's signature platforms include the Diabetes Patient
Engagement System?, a chronic care management and patient engagement
technology developed and tested in a five-year National Institutes of
Health funded study that verified care process improvements and cost
reductions, the Chronic Kidney Disease Patient Engagement System? and
the ESRD Prevention Program?. PES is an IBM (News - Alert) Global Entrepreneurial
Partner, and is a 2011 URAC Bronze Awardee for Best Practice in Health
Care Consumer Empowerment and Protection.
[ Back To Technology News's Homepage ]